Editorial: Terlipressin and MDRO colonisation in cirrhosis—Is there a causal link?
Alimentary Pharmacology & Therapeutics · 2024
DOI: 10.1111/apt.17940 ↗At a glance
Editorial in Alimentary Pharmacology & Therapeutics, 2024. Written by Luciano Revelli and 1 co-authors. Institution: Liver Unit, Hospital Privado de Rosario, Santa Fe, Argentina. Major MEDLINE topics: Terlipressin, Liver Cirrhosis, Vasoconstrictor Agents. Cited 1 times so far (Crossref); 8 references.
Abstract (original language)
LINKED CONTENT This article is linked to Mücke et al paper. To view this article, visit https://doi.org/10.1111/apt.17899
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Liver Unit, Hospital Privado de Rosario, Santa Fe, Argentina.
ORCID profiles: Melisa Dirchwolf
Cite
APA
Revelli, L., & Dirchwolf, M. (2024). Editorial: Terlipressin and MDRO colonisation in cirrhosis—Is there a causal link?. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.17940
Vancouver
Revelli L, Dirchwolf M. Editorial: Terlipressin and MDRO colonisation in cirrhosis—Is there a causal link?. Alimentary Pharmacology & Therapeutics. 2024. doi:10.1111/apt.17940
BibTeX
@article{Revelli2024,
author = {Revelli, Luciano and Dirchwolf, Melisa},
title = {Editorial: Terlipressin and MDRO colonisation in cirrhosis—Is there a causal link?},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2024},
doi = {10.1111/apt.17940}
}
EUVIMED